STRATA Skin Sciences Reports Third Quarter 2024 Financial Results and Provides a Corporate Update |
Globe Newswire |
11/13 |
16:05 |
DMC Global Announces Michael Kuta to Retire as President, CEO and Director; Executive Chairman James O’Leary Will Serve as Interim President & CEO |
Globe Newswire |
11/13 |
16:05 |
Jones Soda Reports Third Quarter 2024 Results |
Globe Newswire |
11/13 |
16:05 |
LPL Financial Hosts Program Leadership Conference for Top Bank and Credit Union Program Executives |
Globe Newswire |
11/13 |
16:05 |
Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results |
Globe Newswire |
11/13 |
16:05 |
Alvotech Reports Financial Results for the First Nine Months of 2024 |
Globe Newswire |
11/13 |
16:05 |
DEADLINE ALERT for BMBL, MGX, POWW, FNA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders |
Globe Newswire |
11/13 |
16:02 |
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iLearningEngines, Inc. (AILE) |
Globe Newswire |
11/13 |
16:02 |
Ibotta Reports Third Quarter 2024 Financial Results |
Globe Newswire |
11/13 |
16:02 |
AirJoule Technologies Announces Third Quarter 2024 Results |
Globe Newswire |
11/13 |
16:01 |
Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update |
Globe Newswire |
11/13 |
16:01 |
Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity |
Globe Newswire |
11/13 |
16:01 |
Synaptics Incorporated Announces Proposed Convertible Senior Notes Offering |
Globe Newswire |
11/13 |
16:01 |
Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results |
Globe Newswire |
11/13 |
16:01 |
Snail, Inc. Reports Third Quarter 2024 Financial Results |
Globe Newswire |
11/13 |
16:01 |
Conifer Holdings Reports 2024 Third Quarter Financial Results |
Globe Newswire |
11/13 |
16:01 |
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax |
Globe Newswire |
11/13 |
16:01 |
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024 |
Globe Newswire |
11/13 |
16:01 |
Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update |
Globe Newswire |
11/13 |
16:01 |
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update |
Globe Newswire |
11/13 |
16:01 |
Oxbridge Re Reports Update on its RWA Tokenized Security, its Business and Third Quarter 2024 Results |
Globe Newswire |
11/13 |
16:01 |
Rhythm Pharmaceuticals Announces New Employment Inducement Grants |
Globe Newswire |
11/13 |
16:01 |
Vireo Growth Inc. Announces Third Quarter 2024 Results |
Globe Newswire |
11/13 |
16:01 |
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress |
Globe Newswire |
11/13 |
16:01 |
electroCore Announces Third Quarter 2024 Financial Results |
Globe Newswire |
11/13 |
16:01 |